[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech]
- PMID: 20194001
- DOI: 10.1016/j.lpm.2010.01.002
[Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech]
Similar articles
-
Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.Int J Clin Pract. 2010 Jun;64(7):995. doi: 10.1111/j.1742-1241.2009.02323.x. Int J Clin Pract. 2010. PMID: 20584233 No abstract available.
-
Clinical trial for Fabry disease faces continuing hurdles.CMAJ. 2009 Nov 24;181(11):E251-2. doi: 10.1503/cmaj.109-3071. Epub 2009 Oct 13. CMAJ. 2009. PMID: 19825933 Free PMC article. No abstract available.
-
Fabry disease: is there a role for enzyme replacement therapy?J Intern Med. 2013 Oct;274(4):329-30. doi: 10.1111/joim.12089. Epub 2013 May 30. J Intern Med. 2013. PMID: 23662843 No abstract available.
-
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.J Am Soc Nephrol. 2018 Sep;29(9):2265-2278. doi: 10.1681/ASN.2018030329. Epub 2018 Aug 9. J Am Soc Nephrol. 2018. PMID: 30093456 Free PMC article. Review. No abstract available.
-
Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.J Nephrol. 2013 Jul-Aug;26(4):645-51. doi: 10.5301/jn.5000214. Epub 2012 Sep 19. J Nephrol. 2013. PMID: 23023720 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical